|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 502-510, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
KN Fenton, MK Heinemann and FL Hanley
The in utero correction of congenital cardiac malformations requires the
availability of fetal cardiac bypass. One difficulty with fetal cardiac
bypass is that very high flow rates are necessary when the placenta is left
in the bypass circuit; the placenta requires about 40% of fetal cardiac
output, which results in a normal cardiac output of 400 ml/kg per minute.
Previous attempts to perform fetal cardiac bypass failed to consistently
achieve these high flow rates because of cannula size limitations. On the
basis of previous work done in our laboratory with an isolated-placenta
model, which demonstrated that at normothermia the placenta would tolerate
at least 30 minutes of cessation of umbilical blood flow, we hypothesized
that exclusion of the placenta from the fetal cardiac bypass circuit would
reduce fetal cardiac output by one half and allow us to obtain better
systemic perfusion without compromising placental function. Cardiac bypass
was performed in 20 late-gestation fetal lambs. In 10 lambs, no drugs were
given; 5 served as controls in which the placenta was perfused; in the last
5, the placenta was excluded by clamping the umbilical cord during bypass.
The latter 10 lambs were treated with indomethacin, which is known to
improve placental blood flow after fetal cardiac bypass. We measured blood
gases and determined regional blood flow with radiolabeled microspheres to
assess placental function after bypass. The 5 control fetuses experienced
rapid hypercapnea and hypoxemia after bypass, in association with minimal
placental blood flow; when the placenta was excluded, arterial carbon
dioxide tension rose somewhat more slowly, and placental blood flow after
bypass was significantly better. When indomethacin was given, arterial
blood gases in both groups showed a mild increase in carbon dioxide tension
and similar placental blood flows (about 30% of baseline) after bypass.
Indomethacin is known to block the vasoconstrictive response of the
placenta to fetal cardiac bypass, implicating the release of vasoactive
cyclooxygenase products as the cause of the adverse effects. In this study,
placental perfusion on bypass without indomethacin caused much more severe
placental dysfunction than did bypass with the placenta excluded from the
circuit. The use of indomethacin improved postbypass placental function in
both groups, but this effect was much more dramatic in the
placenta-perfused group.(ABSTRACT TRUNCATED AT 400 WORDS)
ARTICLES
Exclusion of the placenta during fetal cardiac bypass augments systemic flow and provides important information about the mechanism of placental injury
Department of Cardiac Surgery, Children's Hospital, Harvard Medical School, Boston, Mass.
This article has been cited by other articles:
![]() |
R. S. Baker, C. T. Lam, E. A. Heeb, and P. Eghtesady Dynamic fluid shifts induced by fetal bypass. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 714 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Lam, S. Sharma, R. S. Baker, J. Hilshorst, J. Lombardi, K. E. Clark, and P. Eghtesady Fetal Stress Response to Fetal Cardiac Surgery Ann. Thorac. Surg., May 1, 2008; 85(5): 1719 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lombardi, J. Sedgwick, J. Schenbeck, W. Lubbers, R. E Ferguson, A. Gardner, J. L McNamara, and P. Eghtesady Cardiopulmonary bypass in the immature fetus through novel use of a mini-centrifugal pump Perfusion, May 1, 2006; 21(3): 185 - 191. [Abstract] [PDF] |
||||
![]() |
P. Eghtesady, J. A. Sedgwick, J. L. Schenbeck, C. Lam, J. Lombardi, R. Ferguson, A. Gardner, J. McNamara, and P. Manning Maternal-Fetal Interactions in Fetal Cardiac Surgery Ann. Thorac. Surg., January 1, 2006; 81(1): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Oishi, M. Masuda, T. Yasutsune, N. Boku, S. Tokunaga, S. Morita, and H. Yasui Impaired Endothelial Function of the Umbilical Artery After Fetal Cardiac Bypass Ann. Thorac. Surg., December 1, 2004; 78(6): 1999 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Malhotra, S. Thelitz, R. K. Riemer, V. M. Reddy, S. Suleman, and F. L. Hanley Fetal myocardial protection is markedly improved by reduced cardioplegic calcium content Ann. Thorac. Surg., June 1, 2003; 75(6): 1937 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Malhotra, S. Thelitz, R. K. Riemer, V. M. Reddy, S. Suleman, and F. L. Hanley Induced fibrillation is equally effective as crystalloid cardioplegia in the protection of fetal myocardial function J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1276 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Assad, F. Y. Lee, and F. L. Hanley Placental compliance during fetal extracorporeal circulation J Appl Physiol, May 1, 2001; 90(5): 1882 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Assad and F. L. Hanley Editorial: Artificial placenta--a need for fetal surgery? J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1021 - 1025. [Full Text] [PDF] |
||||
![]() |
J. J Sistino Foetal bypass: concepts and controversies Perfusion, March 1, 1998; 13(2): 111 - 117. [Abstract] [PDF] |
||||
![]() |
K. N. Fenton, M. K. Heinemann, P. R. Hickey, R. J. M. Klautz, J. R. Liddicoat, and F. L. Hanley Inhibition of the fetal stress response improves cardiac output and gas exchange after fetal cardiac bypass J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1416 - 1422. [Abstract] [Full Text] |
||||
![]() |
K. N. Fenton, H. E. Zinn, M. K. Heinemann, J. R. Liddicoat, and F. L. Hanley Long-term survivors of fetal cardiac bypass in lambs J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1423 - 1427. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |